Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak
Titel:
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak
Auteur:
Martin, Sophie Pflumio, Carole Trensz, Philippe Schaff-Wendling, Frederique Weindling, Michal Kalish- Fischbach, Cathie Pierard, Laure Limacher, Jean-Marc Nader, Rita Velten, Michel Petit, Thierry